Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.8.0.1
Stock-Based Compensation (Tables)
6 Months Ended
Sep. 30, 2017
Stockholders' Equity.  
Summary of stock-based compensation expense by statement of operations line item

The following table summarizes, by statement of operations line item, stock-based compensation expense for the Company’s three and six months ended September 30, 2017 and 2016 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

September 30,

 

September 30,

 

 

    

2017

    

2016

    

2017

    

2016

 

Cost of goods sold

 

$

18

    

$

14

 

$

38

    

$

29

 

Research and development

 

 

 5

 

 

13

 

 

12

 

 

16

 

Selling, general and administrative

 

 

130

 

 

214

 

 

257

 

 

434

 

Stock-based compensation expense

 

$

153

 

$

241

 

$

307

 

$

479

 

 

Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Weighted-

 

Remaining

 

Aggregate

 

 

 

 

 

Average

 

Contractual

 

Intrinsic

 

 

 

Shares

 

Exercise Price

 

Term

 

Value

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Options outstanding at March 31, 2017

    

314,537

    

$

15.48

    

 

    

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

 

Exercised

 

 —

 

$

 —

 

 

 

 

 

 

Forfeited, cancelled or expired

 

(4,000)

 

$

24.25

 

 

 

 

 

 

Options outstanding at September 30, 2017

 

310,537

 

$

15.37

 

4.9

 

 

 —

 

Options fully vested at September 30, 2017 and those expected to vest beyond September 30, 2017

 

310,537

 

$

15.37

 

4.9

 

 

 —

 

Options exercisable at September 30, 2017

 

245,693

 

$

18.98

 

3.9

 

 

 —

 

 

Schedule of weighted-average assumptions used to calculate the estimated fair value of each stock option

 

 

 

 

 

 

 

Three and Six Months Ended

 

 

September 30, 2016

Risk-free interest rates

 

 

1.3

%  

Expected lives (in years)

 

 

5.7

 

Dividend yield

 

 

 —

%  

Expected volatility

 

 

133.9

%  

Weighted average grant date fair value of options granted during the period

 

$

1.52

 

 

Summary of restricted stock unit and performance restricted stock unit activity

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average Grant

 

 

 

 

 

Date Fair

 

Restricted Stock and Performance Restricted Stock Units

 

Shares

 

Value

 

Nonvested restricted stock units outstanding at March 31, 2017

    

316,709

    

$

2.85

 

Granted

 

474,848

 

 

0.64

 

Vested and issued

 

(212,924)

 

 

2.76

 

Forfeited

 

(9,513)

 

 

2.49

 

Nonvested restricted stock units outstanding at September 30, 2017

 

569,120

 

 

1.05

 

Restricted stock units expected to vest beyond September 30, 2017

 

569,097

 

$

1.05

 

 

Schedule of additional information on restricted stock units

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

September 30,

 

September 30,

 

 

    

2017

    

2016

    

2017

    

2016

 

Restricted stock compensation expense (in thousands)

 

$

144

    

$

188

 

$

287

    

$

375

 

Aggregate fair value of restricted stock units vested and issued (in thousands)

 

$

130

 

$

85

 

$

137

 

$

107

 

Weighted average grant date fair value of restricted stock units granted during the period

 

$

0.62

 

$

1.71

 

$

0.67

 

$

1.71

 

 

Schedule of restricted stock award activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

September 30,

 

September 30,

 

 

    

2017

    

2016

    

2017

    

2016

 

Restricted stock awards compensation expense (in thousands)

 

$

 1

 

$

50

 

$

 3

    

$

101

 

Restricted stock awards granted

 

 

1,953

 

 

29,910

 

 

3,969

 

 

62,111

 

Weighted average grant date fair value of restricted stock awards granted during the period

 

$

0.64

 

$

1.69

 

$

0.63

 

$

1.63